Ekso Bionics Holdings Inc [NASDAQ: EKSO] loss -7.92% or -0.35 points to close at $4.07 with a heavy trading volume of 5457607 shares.
It opened the trading session at $4.25, the shares rose to $4.4635 and dropped to $3.51, the range by which the price of stock traded the whole day. The daily chart for EKSO points out that the company has recorded -5.57% loss over the past six months.
If we look at the average trading volume of 47.88K shares, EKSO reached to a volume of 5457607 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Ekso Bionics Holdings Inc [EKSO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EKSO shares is $49.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EKSO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
SunTrust have made an estimate for Ekso Bionics Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 14, 2016.
The Price to Book ratio for the last quarter was 1.10, with the Price to Cash per share for the same quarter was set at 0.80.
Trading performance analysis for EKSO stock
Ekso Bionics Holdings Inc [EKSO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.95. With this latest performance, EKSO shares dropped by -20.66% in over the last four-week period, additionally sinking by -5.57% over the last 6 months – not to mention a drop of -55.52% in the past year of trading.
Ekso Bionics Holdings Inc [EKSO]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Ekso Bionics Holdings Inc [EKSO] shares currently have an operating margin of -74.90% and a Gross Margin at 53.48%. Ekso Bionics Holdings Inc’s Net Margin is presently recorded at -70.74%.
Ekso Bionics Holdings Inc (EKSO) Capital Structure & Debt Analysis
According to recent financial data for Ekso Bionics Holdings Inc. ( EKSO), the Return on Equity (ROE) stands at -85.01%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -41.02%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Ekso Bionics Holdings Inc’s Return on Invested Capital (ROIC) is -94.98%, showcasing its effectiveness in deploying capital for earnings.
Ekso Bionics Holdings Inc (EKSO) Efficiency & Liquidity Metrics
Based on Ekso Bionics Holdings Inc’s (EKSO) latest financial statements, the Debt-to-Equity Ratio is 0.51%, indicating its reliance on debt financing relative to shareholder equity.
Ekso Bionics Holdings Inc (EKSO) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Ekso Bionics Holdings Inc. (EKSO) effectively leverages its workforce, generating an average of -$170983.61 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.66% and a Quick Ratio of 1.09%, indicating strong ability to cover short-term liabilities.
Ekso Bionics Holdings Inc [EKSO]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EKSO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Ekso Bionics Holdings Inc go to 80.74%.
An analysis of Institutional ownership at Ekso Bionics Holdings Inc [EKSO]
There are presently around $7.73%, or 8.22%% of EKSO stock, in the hands of institutional investors. The top three institutional holders of EKSO stocks are: KENT LAKE CAPITAL LLC with ownership of 0.7 million shares, which is approximately 0.1419%. VANGUARD GROUP INC, holding 0.59 million shares of the stock with an approximate value of $$0.63 million in EKSO stocks shares; and VANGUARD GROUP INC, currently with $$0.32 million in EKSO stock with ownership which is approximately 0.0612%.
